HUTCHMED Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Public

  • Employees
  • 1,796

Employees

  • Stock Symbol
  • HCM

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $3.01
  • (As of Thursday Closing)

HUTCHMED General Information

Description

HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.

Contact Information

Website
www.hutch-med.com
Formerly Known As
Chi-Med
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 48th Floor, Cheung Kong Center
  • 2 Queen's Road Central
  • Hong Kong
  • Hong Kong
+852 2128
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Stock Exchange
LON
Vertical(s)
Manufacturing, Life Sciences, Oncology
Corporate Office
  • 48th Floor, Cheung Kong Center
  • 2 Queen's Road Central
  • Hong Kong
  • Hong Kong
+852 2128

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HUTCHMED Stock Performance

As of 12-Nov-2026, HUTCHMED’s stock price is $3.01. Its current market cap is $2.62B with 869M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.01 $2.99 $1.99 - $3.25 $2.62B 869M 40.6K $0.02

HUTCHMED Financials Summary

As of 30-Jun-2026, HUTCHMED has a trailing 12-month revenue of $549M.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 609,679 1,172,395 1,817,425 2,269,408
Revenue 549,122 548,512 630,201 837,999
EBITDA 31,014 464,987 (25,974) 31,129
Net Income 17,883 456,909 37,729 100,780
Total Assets 1,736,427 1,753,097 1,274,196 1,279,773
Total Debt 94,508 97,893 89,820 86,131
Public Fundamental Data provided by Morningstar, Inc. disclaimer

HUTCHMED Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore HUTCHMED‘s full profile, request access.

Request a free trial

HUTCHMED Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HUTCHMED Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore HUTCHMED‘s full profile, request access.

Request a free trial

HUTCHMED Investments & Acquisitions (3)

HUTCHMED’s most recent deal was a Merger/Acquisition with Nutrition Science Partners for . The deal was made on 09-Dec-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Nutrition Science Partners 09-Dec-2019 Merger/Acquisition Laboratory Services (Healthcare)
Shanghai Hutchison Whampoa 08-Nov-2019 Merger/Acquisition Distributors/Wholesale
Nutrition Science Partners 13-Aug-2014 Joint Venture Laboratory Services (Healthcare)
To view HUTCHMED’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

HUTCHMED ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

24.65 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,585

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view HUTCHMED’s complete esg history, request access »

HUTCHMED Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Hutchison Medi Pharma Shanghai, China 2002
Shanghai Hutchison Whampoa Shanghai, China 1993

HUTCHMED FAQs

  • When was HUTCHMED founded?

    HUTCHMED was founded in 2000.

  • Where is HUTCHMED headquartered?

    HUTCHMED is headquartered in Hong Kong, Hong Kong.

  • What is the size of HUTCHMED?

    HUTCHMED has 1,796 total employees.

  • What industry is HUTCHMED in?

    HUTCHMED’s primary industry is Biotechnology.

  • Is HUTCHMED a private or public company?

    HUTCHMED is a Public company.

  • What is HUTCHMED’s stock symbol?

    The ticker symbol for HUTCHMED is HCM.

  • What is the current stock price of HUTCHMED?

    As of 12-Nov-2026 the stock price of HUTCHMED is $3.01.

  • What is the current market cap of HUTCHMED?

    The current market capitalization of HUTCHMED is $2.62B.

  • What is HUTCHMED’s current revenue?

    The trailing twelve month revenue for HUTCHMED is $549M.

  • What is HUTCHMED’s annual earnings per share (EPS)?

    HUTCHMED’s EPS for 12 months was $0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process